Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phosphodiesterase 5 Inhibitor”

110 trials

Showing 20 of 110 results

Testing effectiveness (Phase 2)UnknownNCT02028429
What this trial is testing

Efficacy of Sildenafil in the Improvement of Cognition and Quality of Life in Patients With Cirrhosis of Liver. A Proof of Concept Study.

Who this might be right for
Hepatic Encephalopathy.
Post Graduate Institute of Medical Education and Research, Chandigarh 50
Early research (Phase 1)Not Yet RecruitingNCT07732387
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of Viaca (Sildenafil + Cabergoline) Compared With Sildenafil and Cabergoline

Who this might be right for
Erectile DysfunctionsHealthy Volunteer
Yanping Kong 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07266519
What this trial is testing

SIRIUS - Initial Combination Therapy With an Endothelin Receptor Antagonist, a Phosphodiesterase-5 Inhibitor and Sotatercept in Patients With Newly Diagnosed Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension (PAH)
Philipps University Marburg 25
Large-scale testing (Phase 3)Study completedNCT00549302
What this trial is testing

Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs

Who this might be right for
Hypertension, Pulmonary
Eli Lilly and Company 357
Large-scale testing (Phase 3)Study completedNCT02007629
What this trial is testing

Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor

Who this might be right for
Hypertension, Pulmonary
Bayer 61
Early research (Phase 1)Study completedNCT01967264
What this trial is testing

Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults

Who this might be right for
Erectile DysfunctionPhosphodiesterase 5 Inhibitor
Takeda 83
Not applicableStudy completedNCT05043896
What this trial is testing

The Effect of Combination Therapy Using Li-ESWT and PDE-5 Inhibitor in Patients With Erectile Dysfunction

Who this might be right for
Erectile Dysfunction
Dr. Soetomo General Hospital 30
Not applicableStudy completedNCT01150903
What this trial is testing

Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor

Who this might be right for
Erectile DysfunctionCardiovascular DiseasesMale Urogenital Diseases
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 98,832
Large-scale testing (Phase 3)UnknownNCT01696240
What this trial is testing

Trial of Udenafil Therapy in Patients With Mild Pulmonary Hypertension [ULTIMATE-Mild PHT]

Who this might be right for
Mild Pulmonary Hypertension
Seoul National University Hospital 40
Large-scale testing (Phase 3)Study completedNCT01280266
What this trial is testing

Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon

Who this might be right for
Raynaud Phenomenon
Seoul National University Hospital 29
Large-scale testing (Phase 3)WithdrawnNCT00760916
What this trial is testing

FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Hypertension
United Therapeutics
Post-approval studies (Phase 4)Looking for participantsNCT07753720
What this trial is testing

Daily Tadalafil as Adjunctive Therapy Versus Monotherapy for PDE5 Inhibitor-Resistant Erectile Dysfunction

Who this might be right for
Erectile DysfunctionTadalafil
Al-Azhar University 260
Large-scale testing (Phase 3)Study completedNCT07761806
What this trial is testing

Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile Dysfunction

Who this might be right for
Erectile Dysfunction
Ain Shams University 75
Post-approval studies (Phase 4)Ended earlyNCT00867815
What this trial is testing

PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Anterior Ischemic Optic Neuropathy
Bayer 10
Post-approval studies (Phase 4)Study completedNCT00668096
What this trial is testing

A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.

Who this might be right for
Erectile Dysfunction
Bayer 260
Not applicableLooking for participantsNCT01347216
What this trial is testing

COMPERA / COMPERA-KIDS

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Hypertension (PH)
Technische Universität Dresden 14,000
Not applicableStudy completedNCT00874185
What this trial is testing

Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk

Who this might be right for
Erectile Dysfunction
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 720
Testing effectiveness (Phase 2)Study completedNCT02601989
What this trial is testing

Effects on Insulin Resistance With Tadalafil in Type 2 Diabetes - a Double-blind, Placebo-controlled Crossover Study

Who this might be right for
Diabetes Mellitus, Type 2
Göteborg University 23
Not applicableStudy completedNCT00843635
What this trial is testing

Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx

Who this might be right for
Head and Neck Cancer
Donald T. Weed 35
Post-approval studies (Phase 4)Study completedNCT01122264
What this trial is testing

A Study in Patients With Erectile Dysfunction

Who this might be right for
Erectile Dysfunction
Eli Lilly and Company 770
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation